Abdelrahman Karmi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Balakrishnan Solaimuthu, Anees Khatib, Mayur Tanna, Abdelrahman Karmi, Arata Hayashi, Areej Abu Rmaileh, Michal Lichtenstein, Suranjana Takoe, Mohit Kumar Jolly, Yoav David Shaul
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America 121 (3) (2024)
Balakrishnan Solaimuthu, Anees Khatib, Mayur Tanna, Abdelrahman Karmi, Arata Hayashi, Areej Abu Rmaileh, Michal Lichtenstein, Suranjana Takoe, Mohit Kumar Jolly, Yoav David Shaul
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America 121 (3) (2024)
Balakrishnan Solaimuthu, Anees Khatib, Mayur Tanna, Abdelrahman Karmi, Arata Hayashi, Areej Abu Rmaileh, Michal Lichtenstein, Suranjana Takoe, Mohit Kumar Jolly, Yoav David Shaul
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America 121 (3) (2024)
Balakrishnan Solaimuthu, Anees Khatib, Mayur Tanna, Abdelrahman Karmi, Arata Hayashi, Areej Abu Rmaileh, Michal Lichtenstein, Suranjana Takoe, Mohit Kumar Jolly, Yoav David Shaul
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America 121 (3) (2024)
Balakrishnan Solaimuthu, Anees Khatib, Mayur Tanna, Abdelrahman Karmi, Arata Hayashi, Areej Abu Rmaileh, Michal Lichtenstein, Suranjana Takoe, Mohit Kumar Jolly, Yoav David Shaul
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America 121 (3) (2024)